News
DMIIU
10.02
-0.10%
-0.01
Drugs Made in America Acquisition II Corp. Begins Separate Trading of Shares and Rights
Reuters · 3d ago
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
Barchart · 3d ago
*News On Drugs Made In America Acquisition II Corp. (DMIIU) Now Under DMII
Dow Jones · 3d ago
Drugs Made in America Acquisition II Corp. Delays Quarterly Report Filing
Reuters · 11/17 11:30
Audit Report Released for Drugs Made in America Acquisition II Corp.’s Financial Statements
Reuters · 10/02 21:15
Drugs Made In America Acquisition II LLC Reports Disposal of Common Shares of Drugs Made in America Acquisition II Corp
Reuters · 10/01 14:38
Drugs Made In America Acquisition II Corp. Launches $500 Million IPO, Begins Trading on Nasdaq Under Ticker "DMIIU
Reuters · 09/29 21:29
U.S. IPO Weekly Recap: One Small Debut As More Names Join The Pipeline
Seeking Alpha · 09/27 04:30
DRUGS MADE IN AMERICA ACQUISITION II CORP. ANNOUNCES CLOSING OF $500,000,000 INITIAL PUBLIC OFFERING
Reuters · 09/26 20:05
*Drugs Made in America Acquisition II Announces Pricing of $500M Initial Public Offering
Dow Jones · 09/25 10:48
More
Webull provides a variety of real-time DMIIU stock news. You can receive the latest news about Drugs Made In America Acquisition II Corp. through multiple platforms. This information may help you make smarter investment decisions.
About DMIIU
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company is neither engaged in any operations nor generated any revenues.